Business Description
BioLineRx is an Israel-based company founded in 2003 that focuses on developing and selling treatments for cancer and rare diseases. Its leading product, APHEXDA, is being studied across multiple clinical trials for conditions including sickle cell disease, pancreatic cancer, and multiple myeloma. The company also has a non-surgical skin lesion removal product in development, BL-5010, which uses an acid-based solution applied through a pen-like device.
